Dianne C. Whitfield - 21 Mar 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: Chief Human Resources Officer
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol: TARS
Transactions as of: 21 Mar 2023
Transactions value $: -$12,603
Form type: 4
Filing time: 23 Mar 2023, 19:48:38 UTC
Previous filing: 21 Mar 2023
Next filing: 01 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$4.2K	-326	-2.67%	$12.89	11.9K	21 Mar 2023	Direct	F1
transaction	TARS	Common Stock	Sale	-$4.21K	-333	-2.8%	$12.64	11.6K	22 Mar 2023	Direct	F1
transaction	TARS	Common Stock	Sale	-$4.19K	-345	-2.98%	$12.15	11.2K	23 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.